What is the relationship between diabetic nephropathy and hyperkalemia? Read on to learn more about the link between these two conditions.

A study finds hyperkalemia in about one in six patients with diabetes, portending worse outcomes and death.

Hyperkalemia is an important complication of adrenalectomy for patients with primary aldosteronism (PA). The frequency of hyperkalemia after medication using mineralocorticoid receptor antagonists ...

Clinical Challenges > Hyperkalemia Clinical Challenges: Managing Chronic Hyperkalemia — Treatment, risk factors, and possibilities for prevention by Mike Bassett, Contributing Writer, MedPage ...

Use of TMP-SMX may increase risk for hyperkalemia requiring hospitalization in older adults, but there is no added risk when used in combination with beta-blockers.

Cardiology > CHF Hyperkalemia Pipeline Promising — Novel agents look good in trials, although long-term safety and efficacy remain to be seen. by Kristina Fiore, Staff Writer, MedPage Today ...

Hyperkalemia is a high level of potassium in the body. When potassium in the blood is above 5.5 mmol/l, it is called hyperkalemia and can lead to fatal changes in heart rhythm.

Medical nutritional therapy may need to be combined with anti-hyperkalemia therapy to prevent recurrence, investigators suggested.

Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had significantly lower blood potassium levels when taking patiromer—a drug that helps to ...

An analysis of transgender teens prescribed spironolactone showed that only 2.2% developed hyperkalemia after initiating therapy, with all cases resolving upon repeat measurement irrespective of ...

Technavio has announced their latest pipeline analysis report on the hyperkalemia market, including a detailed study of the pipeline molecules.

Technavio analysts forecast the global hyperkalemia drugs market to grow at a CAGR of over 20% during the period 2019-2023.